Genna Jenkins has more than 8 years of experience in regulatory affairs. Genna’s experience spans USDA-BRS-APHIS, FDA-CDER, FDA-CBER, and FDA-Medical Devices across oncology, neurology, therapeutics, infectious disease, and transgenic organisms. Genna has early-phase experience across various product classes and late-stage oncology experience.
Before joining Halloran, Genna was the Director of Regulatory Affairs at Ventria Bioscience Inc., a biopharmaceutical developer and biomanufacturer, where she facilitated regulatory compliance, site inspections, managed existing early-phase submissions, authored CMC content, and provided project management and collaborative support both internally and externally for various cross-functional groups. In tandem with her regulatory and project management roles, Genna functioned as a Research Scientist in the Department of Molecular Biology where she participated in the development of recombinant proteins and antibodies, regeneration of transgenic organisms, and production of critical raw materials.
Genna has a BS in Political Science and an MS in Plant Pathology, both from Kansas State University.